Quantum computing is quickly becoming more science than fiction, and Boehringer Ingelheim hopes to be out in front in bringing it to biopharma R&D. Through a new partnership with Google, the drugmaker hopes to harness its promised speeds and capabilities to simulate the body’s biological mechanics at the molecular level and help discover and design new treatments. The three-year pharmaceutical project is the first of its type for Google’s Quantum AI division, and will be co-led by… Source link
Read More »